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Introduction: This study determined the association of TLR4 Asp299Gly and Thr399Ile with uncomplicated and
severe malaria among Nigerian children of similar ethnic background in Lagos. The association of these SNPs with
high parasite density, malnutrition, hyperpyrexia and anaemia was also investigated.
Methods: Genomic DNA of the study participants was screened for the genotypes of TLR4 Asp299Gly and
Thr399Ile by PCR-RFLP. Anthropometric measurement was performed on the Pf infected children stratified into
asymptomatic malaria (control), uncomplicated and severe malaria (case). Parasites were detected by light
microscopy and Hardy Weinberg Equilibrium (HWE) of SNP genotypes was also determined.
Results: A total of 279 children comprising 182 children (62.1 % male; mean ± SEM age, 57.3 ± 1.7 months) with
clinical falciparum malaria and 97 children (55.7 % male; mean ± SEM age, 55.6 ± 2.5 years) with asymptomatic
falciparum malaria were enrolled. All the genotypes of both TLR4 SNPs were found in the study population with their
minor alleles: 299Gly and 399Ile, found to be 17.6 % and 14.7 % in severe malaria children. Unlike in asymptomatic
population, the genotype distribution of TLR4 Asp299Gly SNP was not in HWE in the clinical malaria group but did not
condition susceptibility. However, Asp299Gly and Thr399Ile polymorphisms were found to increase the risk of severe
malaria 3-fold and 8-fold respectively (P < 0.05). They also increased the risk of severe anaemia, high parasite density
and severe malnutrition 3.8 -5.3-fold, 3.3 – 4.4-fold and 4-fold respectively.
Conclusions: Based on the above findings, we conclude that TLR4 Asp299Gly and Thr399Ile polymorphisms may
modulate susceptibility to severe malaria among Nigerian children of Yoruba ethnic background.Introduction
Despite a reduction by 54 % in the African region since
2000, malaria due to Plasmodium falciparum still ac-
counts for 18 % of child deaths [1, 2]. In 2012, 460,000
deaths out of the estimated 627,000 global malaria
deaths were reported for children below 5 years with
about 86 % of these deaths occurring in sub-Saharan* Correspondence: bamwal@yahoo.com
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creativecommons.org/publicdomain/zero/1.0/Africa [2]. However, severe malaria occurs in less than
5 % of children below 5 years and this has been attributed
to the host genetic factors. [2, 3]. Malaria is an inflamma-
tory disease, which is initiated through recognition of
parasite toxin such as glycophosphatidyl inositol (GPI) by
innate immune cells such as monocytes, dendritic and
macrophages for activation and elicitation of intracellular
signal transduction pathway for the production of pro-
inflammatory cytokines such tumor necrosis factor-alpha
(TNF-α), interleukin-12 (IL-12) and interferon gamma
(IFN-γ) [4, 5]. Timely and appropriate production of these
cytokines in the early phase of infection and their downarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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the later phase of infection has been shown to be crucial
for parasitaemia control and avertion of host tissue
damage and severe malaria [4, 5]. These events have
been observed in infected African children who are
non-susceptible compared to severe malaria susceptible
children [6, 7]. Contrastingly, innate immunity dyregula-
tion has been associated with risk factors and syndromes
of severe malaria, including malnutrition, severe anaemia
hyperparasitaemia or high parasite density [8, 9].
Toll-like receptor 4, a major pathogen recognition re-
ceptor (PRR) expressed on membrane surface of innate
immune cells is genetically encoded by the TLR4 gene
(GeneID = 7099; 9q33.1), which spans a genomic region
of ~13.3 kb with three exons (NCBI; http://www.ncbi.nlm.-
nih.gov/) [10] This PRR is a well-established receptor for
the toxigenic GPI of P. falciparum and Trypanosoma cruzi
as well as for lipopolysaccharide of gram negative bacteria
and other pathogen associated molecular patterns (PAMPS)
in gram positive bacteria, fungi and viruses [10–12].
Meanwhile, in vitro and animal model have shown the
two most-studied non-synonymous single nucleotide poly-
morphisms (SNPs) of TLR4: an A to G transition (SNP ID
= rs4986790), resulting in Aspartate-Glycine substitution
at position 299 (TLR4Asp299Gly) and C to T transition
(SNP ID= rs4986791), resulting in threonine-isoleucine
substitution at position 399 (TLR4Thr399Ile), to cause
altered GPI binding, 50 % reduction in TLR4 expression
on the membrane surface of innate immune cells, induce
LPS hyporesponsiveness and excessive production of
pro-inflammatory cytokines [11, 13, 14]. Subsequent
case–control studies then established associations TLR4
Asp299Gly or Thr399Ile polymorphism with death from
septic shock and susceptibility to typhoid fever, tubercu-
losis, meningitis, chagas disease and respiratory syncytial
virus infection in infected infants, children below 5 years
and adults [11, 15]. However, findings from case–control
studies in malaria endemic countries regarding associ-
ation of these polymorphisms with susceptibility to
clinical and severe malaria have been contradictory
[16–23]. These discrepancies have been based on the
differences geographical location and genetic back-
ground of human populations where these studies were
conducted [16, 23]. Therefore, there is a need for more
immunogenetic studies, regarding the role of TLR4
polymorphisms in malaria pathogenesis, particularly in
other countries with high malaria transmission.
Nigeria is currently among the top there high malaria
burden countries in the world with an annual mortality
of 300,000 deaths and where falciparum malaria
accounts for 30 % of total under-five mortality every
year [24]. Despite evidence from the HapMap project
that the various genotypes of TLR4 Asp299Gly and
Thr399Ile SNPs are in circulation among the Yorubatribe [25], the roles of these SNPs in influencing suscep-
tibility to clinical and severe malaria remain unknown.
It is on this basis that the present study was carried out to
determine the frequency, distribution and association of
mutant genotypes of TLR4 Asp299Gly and Thr399Ile
polymorphisms in a cohort of P. falciparum infected Ni-
gerian children with susceptibility to clinical and severe
malaria.
Methods
Study design and settings
This was a cross sectional study in which convenience
sampling was used to enroll children during two separ-
ate malariometric surveys in Lagos between 2009 –
2011, the first survey was conducted in March – August,
2009 in Takway-Bay, Victoria Island, Lagos, while the
second survey was conducted during the dry season in
January 2011 in Ibeshe Community in Ikorodu. To fur-
ther obtain TLR4 SNPs data from severe malaria cases,
children hospitalized at Massey Street Children Hospital,
Lagos with laboratory and clinical evidence of severe fal-
ciparum malaria between September – October, 2011
were also enrolled into the study. Lagos is located within
the Equatorial tropical region where malaria transmis-
sion mostly driven by female mosquitoes from the
Anopheles gambie complex occurs throughout the year
[26]. In Ibeshe, malaria prevalence rate of 14.2 % (95 %
CI, 13.3 – 16 %) has been previously reported by Aina
et al. [27], while in Takwa-Bay, children below 10 years
account for 76.2 % of cases of uncomplicated malaria
cases seen (Iwalokun et al., unpublished). In this coastal
settlement, malaria treatment practices were generally
poor among caregivers despite their good knowledge of
symptoms of uncomplicated malaria [28]. Massey Street
Children Hospital is a foremost referral health facility of
children in south West Nigeria where management of
severe malaria on yearly basis is very common [29].
Study population
The study population for this study comprised children
(age < 13y) with Plasmodium falciparum positivity slide
results. Asymptomatic malaria was defined as parasit-
aemia without fever in the previous 48 h or other related
malaria symptoms or history of malaria in the preceding
two months. Children in the uncomplicated malaria cat-
egory were those having parasitaemia with fever (axillary
temperature > 37.4 °C) other classical symptoms such as
headache, chill and sweating plus mild-moderate an-
aemia (Hb < 11 g/dL - <9 g/dL), while severe malaria
category were those with severe anaemia, fever plus one
or more of other complications such as prostration,
coma, jaundice, and respiratory distress [30]. At the time
of enrollment, anthropometric measurements were per-
formed with the children wearing light clothing and no
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measured in recumbent position using a wooden horizon-
tal stadiometer, while height of children aged 24 months
and above was measured using a vertical stadiometer.
These children were weighed using appropriate balance to
the nearest 0.1 kg. The anthropometric measurements
were then transformed into z scores with the aid of Epi-
info 2000 software version 3.4 [31] and used for compari-
son with growth curve published by National Centre for
Health statistics (NCHS) [32]. The z-score values for
height for age (HAZ), weight for age (WAZ) and weight
for height (WHZ) < −2 SD were defined as stunting,
under weight and wasting based on the NCHS indices
[32]. The field enrolled children with asymptomatic and
uncomplicated malaria were treated with arthemether-
Lumefantrine according to the national treatment
guidelines, while those with severe malaria were re-
ferred to Massey Street Children’s Hospital for care with
intramuscular loading dose of arthemether (3.2 mg/kg)
given as a pre-referral treatment [33]. Children who did
not have Yoruba ethnic background, with parasite nega-
tive glass slides and those whose caregivers declined con-
sent were excluded from the study. This study was
ancillary to the malariometric study that was approved by
the institutional review board of the Nigerian Institute of
Medical Research (NIMR-IRB), Lagos –Nigeria.Parasite detection
Parasite was detected and speciated by microscopic
examination of thick (12 μL) and thin (3 μL) blood smear
on grease-free labeled glass slides according to WHO
guidelines. The glass slides were prepared in duplicates
and read by two independent trained microscopists. A
glass slide was considered parasite negative after exam-
ining 200 high power fields without seeing one parasite.
Parasitaemia was measured by counting the number of
parasites against 200–500 leukocytes using the thick
blood film and expressed as number of parasites per 1
microlitre of whole blood, assuming 8000 leukocytes per
1 microlitre of blood.Blood haemoglobin measurement
A drop of finger pricked blood drawn into a microcuvette
was used for the determination of haemoglobin (g/dL)
using a Hemocue machine (Hemocue Hb 201). An-
aemia was defines as Hb below 11 g/dL and in this
study, Hb <7 g/dL was taken as severe malaria.Genomic DNA extraction
The salting out protocol of Miller et al. [34] was used
for the extraction and purification of genomic DNA
from peripheral blood samples of the study participantscollected separately into labeled EDTA vials. DNA puri-
fication was done using the phenol-chloroform method.
TLR4 (Asp299Gly and Thr399Ile) genotyping
The alleles and genotypes of the two studied TLR4 SNPs
were determined by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP)
based method using the previously used primers se-
quences by Nyati et al. [35] (Table 1). All PCR amplifica-
tion reactions were performed in a 20-uL volume PCR
tubes containing 10X PCR buffer, 200 μM each of the
dNTPs, 2.0 mM of MgCl2, 20 pmol of each primer, 1.25
U of Taq DNA polymerase (Promega, USA) and 100 ng
of each genomic DNA as template. In a thermal cyler
(Techne™ Thermal cycler TC-312, Fisher Scientific, UK),
the PCR reaction was then subjected to denaturation at
94 °C for 5 min, followed by 35 cycles of denaturing at
94 °C for 30 s, annealing at 55 °C for 30 s, and extension
at 72 °C for 30 s, and a final extension at 72 °C for
5 min and cooling to 4 °C. Template-free water was used
as a negative control. After amplification, the purified 4-
μL PCR products were subjected to restriction digestion
by NcoI restriction endonuclease (Fermentas) for TLR4
Asp299Gly and by HinfI for TLR4 Thr399Ile with 1 mL
10X enzyme buffer (Fermentas) overnight at 37 °C. The
PCR products yielded 299 bp and 406 bp respectively,
while the digested products yielded same DNA frag-
ments for the wild alleles but decreased to 233 bp and
377 bp fragments for the 299Gly and 399Ile mutant al-
leles respectively, on 3 % agarose gel after electrophor-
esis (Table 1). Each restriction enzyme assay was
duplicated for the confirmation of RFLP results.
Statistical analysis
Data were double-entered into Microsoft Excel 2008 and
Microsoft Access 2008 and validated before analysis
using SPSS statistical software for windows version 15.0
(SPSS Inc, USA). Data were expressed as number and
percentages (%), median and range, mean ± standard
error of mean (SEM) and 95 % confidence intervals
(95 % CI). High parasite density and hyperparasitaemia
were defined as parasitaemia > 10,000/uL and > 250,000/uL
respectively. Axillary body temperature > 40 °C was indica-
tive of hyperpyrexia, while severe malnutrition was de-
fined as WHZ or WAZ or HAZ < −3 relative to NCHS
references. Disparity in mean values between asymptom-
atic control and clinical malaria case was measured by
Student’s t-test, while allele and genotype frequency com-
parison was evaluated by chi-square (χ2) test using SPSS
version 15.0 for windows. Association of TLR4 Asp299Gly
and Thr399Ile polymorphisms with clinical and severe
malaria was measured by calculating odd ratio (OR) and
their 95 % confidence intervals (95 % CI) using dominant
inheritance model [23]. This was due to very low numbers
Table 1 Nucleotide sequences of primers used and amplification conditions








D A E C
TLR4 299TLR4F 5′-GATTAGCATACTTAGACTACTACCTCCATG-3′ 94 (30) 55 (30) 72 (30) 35 249 Nco1 (Fermentas) W = 249
299TLR4R 5-GATCAACTTCTGAAAAAGCATTCCCAC-3′ M= 223 + 26
399TLR4F 5′-GGTTGCTGTTCTCAAAGTGATTTTGGGAGAA-3′ 94 (30) 55 (30) 72 (30) 35 406 Hinf1 (Fermentas) W = 406
399TLR4R 5′-ACCTGAAGACTGGAGAGTGAGTTAAATGCT-3′ M= 377 + 29
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Asp299Gly and Thr399Ile polymorphisms. Therefore, they
were grouped together with their respective heterozygotes
as mutant genotypes for the calculation of odd ratios and
their 95 % CI between clinical malaria cases and the
asymptomatic control and between severe and uncompli-
cated malaria. Odd ratios and their 95 % CI without and
with adjustment were also used to measure association of
the TLR4 SNPs with the malaria disease phenotypes
(i.e. anaemia, severe anaemia, malnutrition, severe malnu-
trition, high parasite density severe) measured as covari-
ates. Adjustment was performed by including only cases
of comparable ages between ASM and clinical malaria for
anaemia, malnutrition (WHZ or WAZ or HAZ < −2) and
gender or age for severe anaemia, severe malnutrition and
high parasite density seen only in clinical malaria cases for
the analysis of genotype distribution of the TLR4 SNPs.
Hardy-Weinberg Equilibrium (HWE) was conducted by
comparing of the observed frequencies of different geno-
types of the two TLR4 SNPs with their expected frequen-
cies under HWE for each study group and outcomes with
P > 0.05 was considered to be in HWE [36]. Genotypic de-
viation of HWE was measured by Pearson’s chi-square
(χ2) statistical test. All statistical outcomes with P-value
< 0.05 were considered to be significant.
Results
A total of 279 children comprising 182 children (62.1 %
male; mean ± SEM age, 57.3 ± 1.7 months) with clinical
falciparum malaria and 97 children (55.7 % male; mean ±
SEM age, 55.6 ± 2.5 months) with asymptomatic falciparum
malaria were enrolled (Table 2).
The prevalence rates of underweight, stunting and
wasting were found to be 22.3 %. 23.8 % and 3.7 %
among the study participants. Among the children with
clinical malaria, 2 (1.1 %), 5 (2.7 %), 15 (8.2 %) elicited
hyperparasitaemia, hyperpyrexia and severe malaria. Be-
tween asymptomatic and clinical malarial children there
was no statistical significance difference (P < 0.05) in
terms of age, sex and being underweight. But variables
such as stunting, wasting and axillary body temperature
and anaemia occurred more significantly (P <0.05) in
symptomatic children (Table 2).All the genotypes of both TLR4 SNPs were found in
the study population (Tables 3 & 4). However, the differ-
ence in the proportions of genotypes of these SNPs be-
tween clinical malaria and asymptomatic control cases
was not significant (P > 0.05) (Table 3). Further stratifica-
tion of the clinical malaria cases showed that the fre-
quencies of the minor alleles: 299Gly and 399Ile, of
these TLR4 SNPs were greater than 10 % (17.6 % and
14.7 % respectively) only in severe malaria children
(Table 3 & 4).
Unlike in asymptomatic population, the genotype dis-
tribution of TLR4 Asp299Gly polymorphism was not in
HWE in the clinical malaria group but did not condition
susceptibility (Tables 3 & 4).
However, with stratification, Asp299Gly and Thr399Ile
polymorphisms were found to increase the risk of severe
malaria 3-fold and 8-fold respectively (P < 0.05) (Table 4).
Further analysis revealed mutant genotypes of these
SNPs to also increase the risk of severe anaemia, high
parasite density and severe malnutrition 3.8 -5.3-fold,
3.3 – 4.4-fold and 4-fold respectively (Table 5).
Discussion
The present study has examined the role of the two
non-synonymous SNPs, rs4986790 (Asp299Gly) and
rs4986791 (Thr399Ile), located at the third exon of the
TLR4 gene in the development of clinical and severe
malaria among children with Yoruba ethnic background.
This selection was based on evidence of existence of the
two SNPs of TLR4 among the Yoruba population
(http://www.hapmap.org) [25]. For the first time in the
setting of P. falciparum malaria, this study has also
found all the genotypes of TLR4 SNPs among children
of Yoruba ethnicity. However, the difference in the num-
bers of mutant genotypes of both TLR4 Asp299Gly and
Thr399Ile SNPs between asymptomatic and clinical mal-
arial children was observed to be non-significant (P <
0.05), translating to lack of association between carriage
of these genetic variants and clinical malaria in the stud-
ied children. Our finding is similar to the report of
Esposito et al. [37]. The workers also did not find signifi-
cant association between the carriage of TLR4 Asp299Gly
SNP and malaria among Burundian children. The MAF of
Table 2 Socio-demographic, Parasitological and clinical characteristics of the Plasmodium falciparum infected children
Parameter Study participants P
Total Clinical malaria Asymptomatic malaria
(n = 279) (n = 182) (n = 97)
Age, median (Range), months 52 (8 – 110) 52 (8 – 110) 51 (10–105) ND
Age, mean ± SEM, months 56.7 ± 1.4 57.3 ± 1.7 55.6 ± 2.5 0.59
Age group, n (%)
6 – 24 14 (5) 8 (4.4) 6 (6.2) 0.54
25 – 59 152 (54.5) 101 (55.5) 51 (52.6) 0.69
60 and above 113 (40.5) 73 (40.1) 40 (41.2) 0.86
Gender
Male, n (%) 167 (59.9) 113 (62.1) 54 (55.7) 0.29
Geometric mean parasite density (95 % CI), parasites/uL 5470 (2,170 – 7,770) 10,200 (5,300 – 15,100) 1,690 (1340 – 2040) <0.001
Hyperparasitaemia
(parasitaemia > 250,000/uL), n (%) High parasite density 2 (0.7) 2 (1.1) 0 (0) ND
(parasitaemia >10,000/uL), n (%) 62 (22.2) 62 (33.2) 0 (0) ND
Axillary body temperature, mean ± SEM, °C 37.1 ± 0.04 37.2 ± 0.05 36.8 ± 0.03 <0.0001
Hyperpyrexia (> 40 °C), n (%) 5 (1.8) 5 (2.7) 0 (0) ND
Hb, mean ± SEM (range), g/dl 11.6 ± 0.1 (4.2 – 14.1) 11.3 ± 0.2 (4.2 – 13.4) 12.2 ± 0.1 (10.2 – 14.1) <0.001
Anaemia (Hb < 11 g/dl), n (%) 49 (17.6) 37 (20.3) 12 (12.4) ND
Severe anaemia, (Hb < 6 g/dl), n (%) 15 (5.4) 15 (8.2) 0 (0)
Indices of malnutrition, n (%)
WAZ (n = 224) 14 (16.9)
< −2 SD 50 (22.3) 36 (25.5) 68 (81.9)
−2 – to 2 SD 171 (76.3) 103 (73.0) 1 (1.2) 0.14
>2 SD 3 (1.4) 2 (1.5)
HAZ (n = 239) 11 (13.3)
< −2 SD 57 (23.8) 46 (29.5) 70 (84.3) 0.006
−2 – to 2 SD 176 (73.6) 106 (67.9) 2 (2.4)
>2 SD 6 (2.6) 4 (2.6) 1 (1.2)
WHZ (n = 215)
< −2 SD 8 (3.7) 7 (5.3) 79 (96.3) 0.001
−2 – to 2 SD 204 (94.9) 125 (94.0) 2 (2.5)
>2 SD 3 (1.4) 1 (0.7)
ND = Not determined. Differences in malnutrition indices: weight for age WAZ), height for age (HAZ) and weight for height (WHZ) z scores between clinical and
asymptomatic malarial children was evaluated with a 2 by 3 contingency table using chi-square (χ2) test. Disparity in mean values was evaluated using Student’s
t-test. P < 0.05 was considered to be significant
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children by these workers is also similar to 5.4 – 7 % range
found in this study. However, unlike in the Burundian
children, we found MAF of 17.6 % and 10.4 % for TLR4
Asp299Gly and Thr399Ile among our severe malaria sub-
group with genotypes containing these alleles further
found to increase the risk of severe malaria 3-fold and 8-
fold respectively. Our findings indicate that the two minor
alleles 299 Gly and 399Ile of TLR4 SNPs are not protective
against severe malaria in the studied children. This is inagreement with the case–control studies conducted in
Ghana [21]. In the Ghanian study, Mockhenhaupt et al.
[21] reported also frequencies of 17.6 % and 24.1 % for
these minor alleles in severe malarials children compared
to 2.4 % and 6.2 % in healthy control. The workers also
found these minor alleles to confer 1.5- and 2.6-fold in-
creased risk of severe malaria respectively. In this study,
we found the Asp299Gly heterozygote genotype in 8.7 %,
9.4 % and 23.5 % among the studied children with asymp-
tomatic, UM and SM. Meanwhile, contrary to our findings
Table 3 Genotype and minor allele frequencies and Hardy Weinberg equilibrium for the selected TLR4 polymorphisms comparing
children with asymptomatic and clinical malaria
TLR4 SNP Genotype/Minor allele Study group *OR (95 % CI) P HWE, χ2 (P)
Total Clinical malaria ASM
(N = 279) (n = 187) (n = 92)
Asp299Gly Asp299Asp, % (Fraction) 88.5 (247/279) 87.7 (164/187) 90.2 (83/92) 1 Clinical malaria = 4.89 (<0.05)
Asp299Gly, % (Fraction) 10.8 (28/279) 10.7 (20/187) 8.7 (8/92)
Gly299Gly, % (Fraction) 0.7 (4/279) 1.6 (3/187) 1.1 (1/92) 1.29 (0.57-2.92) 0.54 ASM = 0.11 (>0.05)
MAF 6.5 (36/558) 7 (26/374) 5.4 (10/184) 0.49
Thr399Ile Thr399Thr, % (Fraction) 94.9 (265/279) 94.7 (177/187) 95.7 (88/92) 1 Clinical malaria = 1.35 (>0.05)
Thr399Ile, % (Fraction) 4.3 (12/279) 4.3 (8/187) 4.3 (4/92)
Ile399Ile, % (Fraction) 0.8 (2/279) 1 (2/187) 0 (0/92) 1.24 (0.58-4.08 0.49 ASM = 0.21 (>0.05)
MAF, % (Fraction) 2.9 (16/558) 3.2 (12/374) 2.2 (4/184) 0.50
MAF =Minor allele frequency, OR = odd ratio, 95 % CI = 95 % confidence intervals, n = number of children screened per sub-group; N = total number of children
screened. *OR was calculated after pooling heterozygous and homozygous mutant genotype frequencies; ASM = asymptomatic malaria; P < 0.05 was considered
to be significant
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Asp299Gly nor Thr399Ile polymorphism was found to be
associated with the risk of severe malaria anaemia and
cerebral malaria in children from Uganda and Cameroun
[17, 23]. This is in spite of the location of these countries
in sub-Saharan Africa. This may not be unconnected with
difference in ethnic background of these children and
sample size coupled with temporal changes in malaria
transmission, occurring in many malaria endemic African
countries that might explain the different genotype and al-
lele frequencies of TLR4 Asp299Gly and Thr399Ile poly-
morphisms reported by these investigators. For instance,
in the Cameroun study of 1,862 children, Apinjo et al.
[23] reported MAF of 0.2 – 8.1 % for both TLR4 polymor-
phisms in asymptomatic and clinical malaria (uncompli-
cated and severe malaria) children from Bantu, Foulbe
and Semi-Bantu ethnic groups. The Ugandan study was
conducted among 137 P. falciparum infected hospitalizedTable 4 Genotype and minor allele frequencies and Hardy Weinber
children with uncomplicated and severe malaria
TLR4 SNP Genotype/Minor allele Study group
Total SM
(N = 187) (n = 17)
Asp299Gly Asp299Asp, % (Fraction) 87.7 (164/187) 70.6 (12/17)
Asp299Gly, % (Fraction) 10.7 (20/187) 23.5 (4/17)
Gly299Gly, % (Fraction) 1.6 (3/187) 5.9 (1/17)
MAF 7 (26/374) 17.6(6/34)
Thr399Ile Thr399Thr, % (Fraction) 94.7 (177/187) 76.5 (13/17)
Thr399Ile, % (Fraction) 4.3 (8/187) 17.6 (3/17)
Ile399Ile, % (Fraction) 1.0 (2/187) 5.9 (1/17)
MAF, % (Fraction) 3.2 (12/374) 14.7 (5/34)
MAF =Minor allele frequency, OR = odd ratio, 95 % CI = 95 % confidence intervals, n
screened. *OR was calculated after pooling heterozygous and homozygous mutant
P < 0.05 was considered to be significantchildren and only the frequency of Asp299Gly was above
10 % (i.e. 12.3 %) in the cerebral malaria group that also
had a frequency of 1.5 % for the Thr399Ile genotype. This
genotype was not found in children with uncomplicated
malaria. In Brazil, where temporal changes from low to
moderate P. vivax and P. falciparum malaria transmission
also occur, contradictory findings, regarding the associ-
ation of TLR4 Asp299Gly polymorphisms with protection
from clinical malaria have been reported [19, 20]. Within
the Amazon region, da Silva et al. [19] found MAF of
5.8 % and 1.5 % for TLR4Asp299Gly polymorphism
among 113 healthy and 535 clinical malaria participants
with this polymorphism eliciting protection against clinical
malaria, while Soares et al. [20] did not find protective ef-
fect of TLR4Asp299Gly among their 44 study participants
in an earlier study.
Taken together, our findings and previous reports on
TLR4 Asp299Gly and Thr399Ile polymorphisms in malariag equilibrium for the selected TLR4 polymorphisms comparing
OR (95 % CI) P HWE, χ2 (P)
UM
(n = 170)
89.4(152/170) 1 SM = 0.21 (>0.05)
9.4 (16/170)
1.2 (2/170) 3.12 (1.11-11.12) 0.02 UM = 1.47 (>0.05)
5.9 (20/340) 0.01
96.5 (164/170) 1 SM = 0.25 (>0.05)
2.9 (5/170)
0.6 (1/170) 8.4 (2.1-33.6) 0.0005 UM = 0.59 (>0.05)
2.1 (7/340) 0.00007
= number of children screened per sub-group; N = total number of children
genotype frequencies; SM = Severe malaria; UM = Uncomplicated malaria;
Table 5 Associations between TLR4 Asp299Gly and Thr399Ile polymorphisms and malaria outcomes, in children with clinical malaria




Asp299Asp 28/164 1 1
Asp299Gly + Gly299Gly 9/23 3.12 (1.12 – 8.67) 0.01 2.87 (1.02 – 7.98), 0.02
TLR4 Thr399Ile polymorphism
Thr399Thr 31/177 1 1
Thr399Ile + Ile399Ile 6/10 7.06 (1.63 -32.1), 0.001 6.63 (1.53 – 30.15), 0.002
Severe Anaemia TLR4 Asp299Gly polymorphism
Asp299Asp 10/164 1 1
Asp299Gly + Gly299Gly 5/23 4.28 (1.12 – 15.8), 0.009 3.81 (1.07 – 13.1), 0.01
TLR4 Thr399Ile polymorphism
Thr399Thr 12/177 1 1
Thr399Ile + Ile399Ile 3 /10 5.89 (1.05 – 30.55), 0.0085 5.25 (0.93 – 27.3), 0.02
Malnutrition (WHZ or WAZ or HAZ < −2)
TLR4 Asp299Gly polymorphism
Asp299Asp 34/164 1 1
Asp299Gly + Gly299Gly 8/23 2.04 (0.72 – 5.67), 0.13 1.93 (0.68 – 5.37), 0.16
TLR4 Thr399Ile polymorphism
Thr399Thr 39/177 1
Thr399Ile + Ile399Ile 3/10 1.1.52 (0.29 -6.95), 0.56 1.37 (0.27 – 6.31), 0.66
Severe malnutrition (WHZ; WAZ or HAZ < −3)
TLR4 Asp299Gly polymorphism
Asp299Asp 10/97 1 1
Asp299Gly + Gly299Gly 4/12 3.87 (0.82 – 17.67), 0.037 3.70 (0.76 – 17.4), 0.05
TLR4 Thr399Ile polymorphism
Thr399Thr 12/100 1 1
Thr399Ile + Ile399Ile 2/9 2.11 (0.27 – 13.26), 0.38 1.79 (0.23 – 11.34), 0.43
High Parasite density
TLR4 Asp299Gly polymorphism 1 1
Asp299Asp 46/164 5.86 (2.09 – 16.96), 0.0007 3.54 (1.19 – 10.76), 0.009
Asp299Gly + Gly299Gly 16/23
TLR4 Thr399Ile polymorphism
Thr399Thr 55/177 1 1
Thr399Ile + Ile399Ile 7/10 5.18 (1.15 – 26.38), 0.01 4.41 (0.97 – 22.54), 0.02
Fever TLR4 Asp299Gly polymorphism
Asp299Asp 48/164 1 1
Asp299Gly + Gly299Gly 10/23 1.86 (0.70 – 4.92), 0.16 0.88 (0.36 – 2.13), 0.76
TLR4 Thr399Ile polymorphism
Thr399Thr 52/177 1 1
Thr399Ile + Ile399Ile 6/10 3.61 (0.05 – 15.99), 0.04 4.27 (1.01 – 18.89), 0.02
OR = Odd ratio; 95 % CI = 95 % confidence interval; aDominant model of inheritance of the TLR4 genotypes was used for the analysis of their association with the
disease phenotypes: anaemia, severe anaemia, malnutrition, severe malnutrition, high parasite density and fever. bOR (95 % CI) adjustment was according to age
and gender; P < 0.05 was taken as significant
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infectious diseases that also provide selection pressure on
TLR4. They include tuberculosis, HIV, gram negative bacter-
ial infection, candidiasis, meningitis and respiratory syncytial
viral infection [5, 11]. Since the burden of these infectious
diseases varies across the various malaria endemic countries,
there is thus a high possibility of differences in their contri-
butions to the evolution of mutant variants of TLR4.
Therefore, the implications of other TLR4 activated in-
fectious diseases stated above highlights one of the limi-
tations of the present study since the children were
enrolled during malariometric surveys and were not
clinically and diagnostically examined for candidemia
and viral infections that may further influence the
phenotypic disposition of TLR4 polymorphism and sub-
sequently impact malaria susceptibility.
In this study and under dorminant model of inherit-
ance, the significant association of the two TLR4 SNPs
with clinical malaria syndromes such as fever, severe an-
aemia and high parasite density was found. This findings
indicate that both TLR SNPs elicit functional effects that
are related to the pathogenesis of falciparum malaria in
the studied children. Similar phenotypic findings were
also reported by Mochenhaupt et al. [22] in Ghanian
pregnant women, the population of whom are also at
high risk of clinical malaria globally. The workers found
TLR4Asp299Gly polymorphism to increase maternal
anemia 4.7-fold after adjustment by age. Here, we have
found both TLR4 Asp299Gly and Thr399Ile polymor-
phisms to cause a 3.8 -5.3-fold increased risk of severe
anaemia and 3.5 – 4.4-fold increased risk of high para-
site density, while Thr399Ile polymorphism alone raised
the risk of fever 5-fold. In addition to Mockhenhaupt
et al. [21], The phenotypic effects of TLR4 polymor-
phisms found in these study suggest that functional vari-
ations may exist between Asp299Gly and Thr399Ile
SNPs of TLR4, regarding their systemic effects in Nigerian
children with clinical malaria. Future studies that will look
the combined effects of these SNPs through haplotype
analysis will be very important. On the contrary, the
functional effects of the two TLR4 SNPs observed in
this study and in previous Ghanian study were absent in
Camerounian children [23]. This disparity again con-
firm that malaria is a complex disease, involving mul-
tiple genetic factors that play different biological roles
in disease manisfestation. Therefore, future haplotype-
malaria association studies are needed to resolve incon-
sistency or heterogenous genotype-phenotype relationships
in the setting of malaria in the African region.
However, of relevance is our finding that the mutant
genotypes of TLR4Asp299Gly increased the risk of se-
vere malnutrition 3.7-fold. However, this observation
needs to be interpreted with caution because it was not
been documented in previous immunogenetic studies ofTLR4 and malaria from other countries. Also because of
the fact that malnutrition is a common health problem
among African children, including Nigeria and many ae-
tiologies have been reported [38, 39]. In fact, it has been
reported that malnutrition accounts for 22 – 40 % of
under –five mortality and malaria is one of the co-
morbid factors [40, 41]. In the study, 3.7 %, of our study
population as a whole elicited wasting, which indicates
acute malnutrition 23.8 % were stunted, indicating
chronic malnutrition and a state of long period of nutri-
ent deprivation, while 22.3 % were underweight. Even in
the setting of P. falciparum infection, these rates appear
to be lower than the national prevalence rates 5.5 %,
35.7 % and 25.2 % and rates reported for children below
5 years in the northern parts of Nigeria. Another reason
for this cautionary interpretation is the fact the present
study is cross-sectional in design and is limited in deter-
mining the cause and effect relationship between malnu-
trition and malaria in the studied children. furthermore,
the malnutrition investigated in this study exluded
micronutrient deficiency such as zinc, iron and vitamin
A deficiency, which have been shown to increase the risk
of severe anaemia, wasting and dyregulated innate im-
munity in malarial children [42].
In conclusion, our findings suggest that TLR4 Asp299Gly
and Thr399Ile polymorphisms among Nigerian children of
Yoruba ethnic background may modulate susceptibility to
severe malaria and other disease outcomes such as severe
anaemia and hyperpyrexia. To further validate the present
findings, functional studies of TLR4 polymorphisms,
haplotype analysis and investigation of other TLR4 acti-
vated infectious diseases in the setting of malaria in this
category of Nigerian children are needed.Competing interests
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